Five-Year Summary

 

 

2012

 

2013

 

2014

 

2015

 

2016

 

 

€ million

 

€ million

 

€ million

 

€ million

 

€ million

2015 figures restated; figures for 2012–2014 as last reported

1

For definitions of the indicators see Chapter “Alternative Performance Measures Used by the Bayer Group.”

2

Employees calculated as full-time equivalents (FTEs)

3

Number of incidents per 200,000 working hours in which chemicals leak from their primary container, such as pipelines, pumps, tanks or drums

4

Quotient of total energy consumption and manufactured sales volume; Life Sciences only

5

Direct emissions from power plants, waste incinerators and production plants and indirect emissions from external supplies of electricity, steam and refrigeration (according to the market-based method); portfolio-adjusted in accordance with the GHG Protocol

6

Life Sciences without Currenta

Bayer Group

 

 

 

 

 

 

 

 

 

 

Sales

 

39,741

 

40,157

 

41,339

 

46,085

 

46,769

EBITDA1

 

6,916

 

7,830

 

8,315

 

9,573

 

10,785

EBITDA before special items1

 

8,280

 

8,401

 

8,685

 

10,256

 

11,302

EBITDA margin before special items1

 

20.8%

 

20.9%

 

21.0%

 

22.3%

 

24.2%

EBIT1

 

3,928

 

4,934

 

5,395

 

6,241

 

7,042

EBIT before special items1

 

5,639

 

5,773

 

5,833

 

7,060

 

8,130

Income before income taxes

 

3,176

 

4,207

 

4,414

 

5,236

 

5,887

Net income (from continuing and discontinued operations)

 

2,403

 

3,189

 

3,426

 

4,110

 

4,531

Earnings per share (from continuing and discontinued operations) (€)1

 

2.91

 

3.86

 

4.14

 

4.97

 

5.44

Core earnings per share (from continuing operations) (€)1

 

5.30

 

5.61

 

5.89

 

6.82

 

7.32

Net cash provided by operating activities (from continuing and discontinued operations)

 

4,530

 

5,171

 

5,810

 

6,890

 

9,089

Net financial debt

 

7,022

 

6,731

 

19,612

 

17,449

 

11,778

Capital expenditures as per segment table

 

2,012

 

2,155

 

2,484

 

2,511

 

2,578

 

 

 

 

 

 

 

 

 

 

 

Bayer AG

 

€ million

 

€ million

 

€ million

 

€ million

 

€ million

Total dividend payment

 

1,571

 

1,737

 

1,861

 

2,067

 

2,233

Dividend per share (€)

 

1.90

 

2.10

 

2.25

 

2.50

 

2.70

 

 

 

 

 

 

 

 

 

 

 

Innovation

 

€ million

 

€ million

 

€ million

 

€ million

 

€ million

Research and development expenses

 

3,013

 

3,406

 

3,537

 

4,274

 

4,666

Ratio of R&D expenses to sales – Pharmaceuticals (%)

 

14.5

 

15.8

 

15.6

 

16.0

 

17.0

Ratio of R&D expenses to sales – Crop Science (%)

 

9.3

 

9.8

 

10.3

 

10.7

 

11.7

Employees in research and development

 

12,900

 

13,509

 

13,900

 

14,753

 

15,229

 

 

 

 

 

 

 

 

 

 

 

Employees

 

 

 

 

 

 

 

 

 

 

Number of employees2 (Dec. 31)

 

110,000

 

112,400

 

117,400

 

116,600

 

115,200

Personnel expenses (including pension expenses) (€ million)

 

9,194

 

9,430

 

9,693

 

11,176

 

11,357

Proportion of women in senior management (%)

 

23

 

25

 

26

 

28

 

29

Proportion of employees with health insurance (%)

 

94

 

95

 

96

 

96

 

98

Fluctuation (voluntary / total) (%)

 

– / 14.1

 

5.5 / 14.0

 

4.8 / 11.4

 

5.0 / 13.9

 

4.6 / 12.3

Hours of vocational and ongoing training per employee

 

 

17.8

 

18.0

 

20.0

 

22.1

 

 

 

 

 

 

 

 

 

 

 

Safety & Environmental Protection

 

 

 

 

 

 

 

 

 

 

Recordable Incident Rate for Bayer employees (RIR)

 

0.49

 

0.47

 

0.43

 

0.42

 

0.39

Loss of Primary Containment Incident Rate (LoPC-IR)3

 

0.38

 

0.35

 

0.23

 

0.22

 

0.32

Total energy consumption (terajoules)

 

83,184

 

80,848

 

85,317

 

83,182

 

84,494

Energy efficiency (MWh/t)4

 

8.86

 

8.54

 

7.62

 

6.34

 

6.77

Total greenhouse gas emissions (CO2 equivalents in million t)5

 

8.96

 

9.00

 

9.55

 

9.71

 

9.87

Specific greenhouse gas emissions (CO2 equivalents in t / manufactured sales volume in t), according to the market-based method6

 

1.88

 

1.83

 

1.72

 

1.69

 

1.54

Hazardous waste generated (thousand t)

 

603

 

467

 

487

 

541

 

547

Water use (million m3)

 

384

 

361

 

350

 

346

 

330